AI Terminal
aap Implantate AG
Share Issue/Capital Change • Dec 4, 2025
10_rns_2025-12-04_ff89289b-7dc6-4be0-b1c1-5af7a0954c00.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 4 December 2025 13:07
aap Implantate AG: Cash capital increase
aap Implantate AG / Key word(s): Capital Increase/Corporate Action
aap Implantate AG: Cash capital increase
04-Dec-2025 / 13:07 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group .
The issuer is solely responsible for the content of this announcement.
The Management Board of aap Implantate AG (the “Company”) today resolved, with the approval of the Supervisory Board, to increase the Company’s share capital from its current level of EUR 13,909,408.00 by EUR 788,150.00 to EUR 14,697,558 by issuing 788150 new no-par value bearer shares, each with a proportional amount of EUR 1.00 in the share capital (“ New Shares”), against cash contributions, partially utilizing the authorized capital 2024/I and excluding shareholders’ subscription rights (“ cash capital increase “). The issue price per New Share is EUR 1.34. The cash capital increase corresponds to approximately 5% of the existing share capital. The New Shares will be issued by way of a private placement to selected investors. The New Shares will be entitled to dividends from January 1, 2025.
The cash capital increase serves to strengthen the company’s equity base. The gross proceeds from the cash capital increase will amount to EUR 1,056,121.00.
*****
Contact:
aap Implantate AG; R. Di Girolamo; Vorsitzender des Vorstands / CEO; Lorenzweg 5; D-12099 Berlin
Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; [email protected]
End of Inside Information
04-Dec-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
| Language: | English |
| Company: | aap Implantate AG |
| Lorenzweg 5 | |
| 12099 Berlin | |
| Germany | |
| Phone: | +49 (0) 30 75 019-0 |
| Fax: | +49 (0) 30 75 019-111 |
| E-mail: | [email protected] |
| Internet: | www.aap.de |
| ISIN: | DE000A3H2101 |
| WKN: | A3H210 |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2240510 |
| End of Announcement | EQS News Service |
2240510 04-Dec-2025 CET/CEST